From the link you provided: "We are optimistic that this data will lead to advancement of dCellVax into clinical trials," said David Koos, PhD, Chairman and CEO of Regen BioPharma.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.